FDA Orange Book · active-ingredient family
Thiothixene hydrochloride
Thiothixene hydrochloride is approved as 2 brand and 6 generic applications in the FDA Orange Book, with their therapeutic-equivalence codes, listed patents, and marketing exclusivity.
Reference-listed drug:NAVANE · NDA 016758
2
Brand (NDA)
6
Generics (ANDA)
0
Listed patents
0
Exclusivity periods
Brand (NDA) products · concentrate, injectable
Generic (ANDA) products (6)
| Product | Applicant | Application | TE | Approved | |
|---|---|---|---|---|---|
| THIOTHIXENE HYDROCHLORIDE INTENSOL | HIKMA | ANDA 073494 | — | Jun 30, 1992 | |
| THIOTHIXENE HYDROCHLORIDE | PACO | ANDA 071917 | — | Sep 20, 1989 | |
| THIOTHIXENE HYDROCHLORIDE | PACO | ANDA 071939 | — | Dec 16, 1988 | |
| THIOTHIXENE HYDROCHLORIDE | ALPHARMA US PHARMS | ANDA 070969 | — | Oct 16, 1987 | |
| THIOTHIXENE HYDROCHLORIDE | TEVA PHARMS | ANDA 071554 | — | Oct 16, 1987 | |
| THIOTHIXENE HYDROCHLORIDE | TEVA | ANDA 071184 | — | Jun 22, 1987 |
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
Thiothixene hydrochloride — frequently asked questions
Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

